Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yusuf Oloruntoyin Ayipo, Iqrar Ahmad, Chien Fung Chong, Nurul Amira Zainurin, Sani Yahaya Najib, Harun Patel & Mohd Nizam Mordi. (2023) Carbazole derivatives as promising competitive and allosteric inhibitors of human serotonin transporter: computational pharmacology. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-22.
Read now
Read now
Jennifer Hong, Darian Vernon, Jelena Kunovac & Stephen Stahl. (2022) Emerging drugs for the treatment of major depressive disorder. Expert Opinion on Emerging Drugs 27:3, pages 263-275.
Read now
Read now
Mirella Stuivenga, Erik J. Giltay, Olivia Cools, Laurence Roosens, Hugo Neels & Bernard Sabbe. (2019) Evaluation of vilazodone for the treatment of depressive and anxiety disorders. Expert Opinion on Pharmacotherapy 20:3, pages 251-260.
Read now
Read now
Jakub Staroń, Ryszard Bugno, Adam S. Hogendorf & Andrzej J. Bojarski. (2018) 5-HT1A receptor ligands and their therapeutic applications: review of new patents. Expert Opinion on Therapeutic Patents 28:9, pages 679-689.
Read now
Read now
Jason L. Russell, Henry A. Spiller, Thiphalak Chounthirath & Marcel J. Casavant. (2017) Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications. Clinical Toxicology 55:5, pages 352-356.
Read now
Read now
Kinjal Patel, Petal S. Abdool, Tarek K. Rajji & Benoit H. Mulsant. (2017) Pharmacotherapy of major depression in late life: what is the role of new agents?. Expert Opinion on Pharmacotherapy 18:6, pages 599-609.
Read now
Read now
Articles from other publishers (45)
N. A. Shnayder, A. V. Kidyaeva, E. E. Vaiman, A. R. Asadullin, M. M. Petrova, D. S. Kaskaeva, G. V. Matyushin, A. A. Evsyukov, E. V. Galko, N. P. Garganeeva, G. A. Chumakova, N. V. Lareva, N. G. Neznanov & R. F. Nasyrova. (2023) Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders. Personalized Psychiatry and Neurology 3:2, pages 72-119.
Crossref
Crossref
Ajayrajsinh R. Zala & Premlata Kumari. (2023) Versatile Therapeutic Values of N‐Containing Heterocycles Benzimidazole, Piperazine and Piperidine Hybrids. ChemistrySelect 8:37.
Crossref
Crossref
N Simple Santi, Sashi B Biswal, Birendra Narayan Naik, Jyoti Prakash Sahoo & Bhabagrahi Rath. (2023) Comparison of Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale: Baked Straight From a Randomized Study. Cureus.
Crossref
Crossref
Dianer Nornberg Strelow, Larissa Sander Magalhães, Mariana Parron Paim, Letícia Devantier Krüger, José Sebastião Santos Neto, César Augusto Brüning & Cristiani Folharini Bortolatto. (2023) Depressive-like behavior and cognitive impairment induced by acute administration of dexamethasone: Pharmacological effects of 2-phenyl-3-(phenylselanyl)benzofuran in female Swiss mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 125, pages 110772.
Crossref
Crossref
Zhi-Zheng Wang, Chao Yi, Jun-Jie Huang, Teng-Fei Xu, Kang-Zhi Chen, Zu-Sheng Wang, Ya-Ping Xue, Jie-Lian Lu, Biao Nie, Ying-Jun Zhang, Chuan-Fei Jin & Ge-Fei Hao. (2023) Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter. Journal of Medicinal Chemistry 66:1, pages 371-383.
Crossref
Crossref
Seth Davin Norrholm. 2023. The Psychology of Panic. The Psychology of Panic.
Mubashir Hassan, Aqsa Amir, Saba Shahzadi & Andrzej Kloczkowski. (2022) Therapeutic Implications of microRNAs in Depressive Disorders: A Review. International Journal of Molecular Sciences 23:21, pages 13530.
Crossref
Crossref
Hala S. El Said, Aikaterini Lalatsa, Abdulaziz M. Al-Mahallawi, Eman Saddar El Leithy & Dalia M. Ghorab. (2022) Vilazodone-phospholipid mixed micelles for enhancing oral bioavailability and reducing pharmacokinetic variability between fed and fasted states. International Journal of Pharmaceutics 625, pages 122080.
Crossref
Crossref
T. S. Sathyanarayana Rao & Chittaranjan Andrade. (2022) Antidepressants and Sexual Dysfunction: Is Vortioxetine Among the Exceptions?. Journal of Psychosexual Health 4:3, pages 155-156.
Crossref
Crossref
Mohit Chauhan, Rebecca Parry & William V Bobo. (2022) Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice. Neuropsychiatric Disease and Treatment Volume 18, pages 1175-1193.
Crossref
Crossref
Sophie R. Cohen, Michelle L. Terry, Michael Coyle, Emily Wheelis, Ashley Centner, Samantha Smith, John Glinski, Natalie Lipari, Carla Budrow, Fredric P. Manfredsson & Christopher Bishop. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacology Biochemistry and Behavior 217, pages 173393.
Crossref
Crossref
Ahmed Ayyash & Alison C. Holloway. (2021)
Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ
12,14
PGJ
2
. Journal of Applied Toxicology 42:6, pages 1004-1015.
Crossref
Crossref
Agnieszka Zagórska, Adam Bucki, Anna Partyka, Magdalena Jastrzębska-Więsek, Agata Siwek, Monika Głuch-Lutwin, Barbara Mordyl, Anna Jaromin, Maria Walczak, Anna Wesołowska & Marcin Kołaczkowski. (2022) Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia. European Journal of Medicinal Chemistry 233, pages 114218.
Crossref
Crossref
Jennifer Yoon, Jason Gu & Katherine B Martin. (2022) A Novel Treatment of Postpartum Depression and Review of Literature. Cureus.
Crossref
Crossref
Taís da Silva Teixeira Rech, Amália Gonçalves Alves, Dianer Nornberg Strelow, Letícia Devantier Krüger, Luiz Roberto Carraro Júnior, José Sebastião dos Santos Neto, Antonio Luiz Braga, César Augusto Brüning & Cristiani Folharini Bortolatto. (2021) 2-Phenyl-3-(phenylselanyl)benzofuran elicits acute antidepressant-like action in male Swiss mice mediated by modulation of the dopaminergic system and reveals therapeutic efficacy in both sexes. Psychopharmacology 238:10, pages 3013-3024.
Crossref
Crossref
Feras Altwal, Fernando E. Padovan-Neto, Alexandra Ritger, Heinz Steiner & Anthony R. West. (2021) Role of 5-HT1A Receptor in Vilazodone-Mediated Suppression of L-DOPA-Induced Dyskinesia and Increased Responsiveness to Cortical Input in Striatal Medium Spiny Neurons in an Animal Model of Parkinson’s Disease. Molecules 26:19, pages 5790.
Crossref
Crossref
Grzegorz Ślifirski, Marek Król & Jadwiga Turło. (2021) 5-HT Receptors and the Development of New Antidepressants. International Journal of Molecular Sciences 22:16, pages 9015.
Crossref
Crossref
Anna Calvi, Ilaria Fischetti, Ignazio Verzicco, Martino Belvederi Murri, Stamatula Zanetidou, Riccardo Volpi, Pietro Coghi, Stefano Tedeschi, Mario Amore & Aderville Cabassi. (2021) Antidepressant Drugs Effects on Blood Pressure. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Manohara Dhulappa Jalageri, Akshatha Nagaraja & Yashoda Malgar Puttaiahgowda. (2021) Piperazine based antimicrobial polymers: a review. RSC Advances 11:25, pages 15213-15230.
Crossref
Crossref
Lorrane Kelle da Silva Moreira, Adriane Ferreira de Brito, Dayane Moreira da Silva, Lorrayne Siqueira, Daiany Priscilla Bueno da Silva, Carina Sofia Cardoso, Iziara Ferreira Florentino, Pablinny Moreira Galdino de Carvalho, Paulo César Ghedini, Ricardo Menegatti & Elson Alves Costa. (2021) Potential antidepressant-like effect of piperazine derivative LQFM212 in mice: Role of monoaminergic pathway and brain-derived neurotrophic factor. Behavioural Brain Research 401, pages 113066.
Crossref
Crossref
Alexei Verkhratsky, Vladimir Parpura, Caterina Scuderi & Baoman Li. 2021. Astrocytes in Psychiatric Disorders. Astrocytes in Psychiatric Disorders
317
347
.
Lauren M. Behlke, Eric J. Lenze & Robert M. Carney. (2020) The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases. CNS Drugs 34:11, pages 1133-1147.
Crossref
Crossref
Anna Partyka, Agnieszka Zagórska, Magdalena Kotańska, Maria Walczak, Magdalena Jastrzębska-Więsek, Joanna Knutelska, Marek Bednarski, Monika Głuch-Lutwin, Barbara Mordyl, Paulina Janiszewska & Anna Wesołowska. (2020) Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists. PLOS ONE 15:8, pages e0237196.
Crossref
Crossref
Jéssica Iara Gall, Amália Gonçalves Alves, Luiz Roberto Carraro Júnior, Taís da Silva Teixeira Rech, José Sebastião dos Santos Neto, Diego Alves, Mayara Sandrielly Pereira Soares, Luiza Spohr, Rosélia Maria Spanevello, César Augusto Brüning & Cristiani Folharini Bortolatto. (2020) Insights into serotonergic and antioxidant mechanisms involved in antidepressant-like action of 2-phenyl-3-(phenylselanyl)benzofuran in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 102, pages 109956.
Crossref
Crossref
Yang Zhang, Guoxun Zheng, Tingting Fu, Jiajun Hong, Fengcheng Li, Xiaojun Yao, Weiwei Xue & Feng Zhu. (2020) The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations. Physical Chemistry Chemical Physics 22:9, pages 5132-5144.
Crossref
Crossref
Enze Jia & Michael G. Bartlett. (2020) Recent advances in liquid chromatographic methods for the determination of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors. Biomedical Chromatography 34:3.
Crossref
Crossref
Wen-Tao Wang, Hao Qian, Jian-Wei Wu, Xiao-Wen Chen & Jian-Qi Li. (2019) Synthesis and antidepressant-like activity of novel alkoxy-piperidine derivatives targeting SSRI/5-HT1A/5-HT7. Bioorganic & Medicinal Chemistry Letters 29:24, pages 126769.
Crossref
Crossref
Le Wang, Yanming Zhang, Xia Du, Teng Ding, Weiling Gong & Feng Liu. (2019) Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. Biomedicine & Pharmacotherapy 120, pages 109408.
Crossref
Crossref
Darakhshan Jabeen Haleem. (2019) Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression. Current Neuropharmacology 17:12, pages 1098-1108.
Crossref
Crossref
Grzegorz Ślifirski, Marek Król, Jerzy Kleps, Piotr Podsadni, Mariusz Belka, Tomasz Bączek, Agata Siwek, Katarzyna Stachowicz, Bernadeta Szewczyk, Gabriel Nowak, Andrzej Bojarski, Anna E. Kozioł, Jadwiga Turło & Franciszek Herold. (2019) Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands. European Journal of Medicinal Chemistry 180, pages 383-397.
Crossref
Crossref
L. Perez-Caballero, S. Torres-Sanchez, C. Romero-López-Alberca, F. González-Saiz, J. A. Mico & Esther Berrocoso. (2019) Monoaminergic system and depression. Cell and Tissue Research 377:1, pages 107-113.
Crossref
Crossref
Gustavo Roberto Villas Boas, Roseli Boerngen de Lacerda, Marina Meirelles Paes, Priscila Gubert, Wagner Luis da Cruz Almeida, Vanessa Cristina Rescia, Pablinny Moreira Galdino de Carvalho, Adryano Augustto Valladao de Carvalho & Silvia Aparecida Oesterreich. (2019) Molecular aspects of depression: A review from neurobiology to treatment. European Journal of Pharmacology 851, pages 99-121.
Crossref
Crossref
Grzegorz Ślifirski, Marek Król, Jerzy Kleps, Szymon Ulenberg, Mariusz Belka, Tomasz Bączek, Agata Siwek, Katarzyna Stachowicz, Bernadeta Szewczyk, Gabriel Nowak, Andrzej Bojarski, Anna E. Kozioł, Jadwiga Turło & Franciszek Herold. (2019) Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands. European Journal of Medicinal Chemistry 166, pages 144-158.
Crossref
Crossref
Silvia Franchini, Leda Ivanova Bencheva, Umberto Maria Battisti, Annalisa Tait, Claudia Sorbi, Paola Fossa, Elena Cichero, Simone Ronsisvalle, Giuseppina Aricò, Nunzio Denora, Rosa Maria Iacobazzi, Antonio Cilia, Lorenza Pirona & Livio Brasili. (2018)
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT
1A
receptor agonists for CNS disorders and neuropathic pain
. Future Medicinal Chemistry 10:18, pages 2137-2154.
Crossref
Crossref
Nikita V. Kudryashov, Tatiana S. Kalinina, Alexander A. Shimshirt, Anton O. Korolev, Anna V. Volkova & Tatiana A. Voronina. (2018) Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice. Behavioural Pharmacology 29:4, pages 375-378.
Crossref
Crossref
Maria Bogdan, Eliza Gofita, Daniela Cornelia Calina, Adina Turcu-Stiolica, Anca Oana Docea, Tudor Adrian Balseanu, Adrian Camen, Gratiela Eliza Popa, Gabriela Rusu, Ina Cristofor, Liliana Pavel & Liliana Mititelu-Tartau. 2018. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors.
Francesc Artigas, Analia Bortolozzi & Pau Celada. (2018) Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies. European Neuropsychopharmacology 28:4, pages 445-456.
Crossref
Crossref
Hairong He, Wei Wang, Jun Lyu, Jie Zheng, Liyang Guo, Xiaofang An, Yajuan Fan & Xiancang Ma. (2018) Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis. Journal of Psychiatric Research 96, pages 247-259.
Crossref
Crossref
Zheng-Song Gu, Ai-nan Zhou, Ying Xiao, Qing-Wei Zhang & Jian-Qi Li. (2018) Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT 1A /5-HT 7. European Journal of Medicinal Chemistry 144, pages 701-715.
Crossref
Crossref
T. E. Schwasinger-Schmidt & M. Macaluso. 2019. Antidepressants. Antidepressants
325
355
.
Zheng-Song Gu, Ying Xiao, Qing-Wei Zhang & Jian-Qi Li. (2017) Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT 1A /5-HT 7. Bioorganic & Medicinal Chemistry Letters 27:24, pages 5420-5423.
Crossref
Crossref
Chihiro Ishikawa & Takashi Shiga. (2017) The postnatal 5-HT1A receptor regulates adult anxiety and depression differently via multiple molecules. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, pages 66-74.
Crossref
Crossref
Berend Olivier. 2017. Sexual Dysfunction. Sexual Dysfunction.
Katherine M. Nautiyal & René Hen. (2017) Serotonin receptors in depression: from A to B. F1000Research 6, pages 123.
Crossref
Crossref
Mark J Millan, Jean-Michel Rivet & Alain Gobert. (2016) The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders. Journal of Psychopharmacology 30:11, pages 1099-1128.
Crossref
Crossref